Sanofi (NASDAQ:SNY) JPMorgan 42nd Annual Healthcare Conference Call January 9, 2024 1:30 PM ET Company Participants Paul Hudson - Chief Executive Officer Jean-Baptiste de Chatillon - Executive Vice President and Chief Financial Officer Houman Ashrafian - Executive Vice President and Head of Research and Development Conference Call Participants Richard Vosser - JPMorgan Richard Vosser Hi, welcome to the Sanofi Presentation at the 42nd JPMorgan Healthcare Conference. I'm Richard Vosser, European Pharma Analys ...

Dell Technologies Inc. (NYSE:DELL) Fireside Chat with Bernstein Conference Transcript January 9, 2024 1:15 PM ET Executives Michael Dell - Founder, Chairman and CEO Analysts Toni Sacconaghi - Bernstein Toni Sacconaghi Good morning, everyone, and welcome. I’m Toni Sacconaghi, Bernstein’s IT Hardware Analyst, and I’m thrilled to have, Michael Dell, Founder and Chairman and CEO of Dell Technologies, join us today for a fireside conversation. Before I begin, I’d just like to read the Safe Harbor. A reading from ...

The Toronto-Dominion Bank (NYSE:TD) RBC Capital Markets Canadian Bank CEO Conference January 9, 2024 1:20 PM ET Company Participants Bharat Masrani - Group President and Chief Executive Officer Conference Call Participants Darko Mihelic - RBC Capital Markets Darko Mihelic Okay. Great. Thank you. We'll start the next session with, TD Bank. I'm pleased to have Bharat Masrani on the stage. Thank you for joining us today, Bharat. Bharat Masrani Nice to be here, Darko. Happy New Year to you and to all of you. Go ...

Danaher Corporation (NYSE:DHR) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2024 2:15 PM ET Company Participants Rainer Blair - President and Chief Executive Officer Conference Call Participants Rachel Vatnsdal - JPMorgan Rachel Vatnsdal Good afternoon, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JP Morgan. Thank you for coming to the Danaher presentation. This will be a 40-minute session as we typically do roughly 20 minutes of a presentation foll ...

Illumina, Inc. (NASDAQ:ILMN) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 12:00 PM ET Company Participants Jacob Thaysen - CEO Joydeep Goswami - CFO, Chief Strategy and Corporate Development Officer Conference Call Participants Rachel Vatnsdal - J.P. Morgan Rachel Vatnsdal Perfect. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team, I'm here with Illumina up on stage. So as these sessions are, it's going to be 40 minutes, roughly 20 minutes of p ...

BioNTech SE (NASDAQ:BNTX) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2024 12:00 PM ET Company Participants Ugur Sahin - CEO Ryan Richardson - Chief Strategy Officer Conference Call Participants Jess Fye - J.P. Morgan Jess Fye Great. Good morning, everyone. My name is Jess Fye. I am a Senior Biotech Analyst at J.P. Morgan, and we’re continuing the conference today with BioNTech. I am joined by the company's CEO, Dr. Ugur Sahin. He is going to give a presentation on the company and then we are g ...

Novartis AG (NYSE:NVS) 2024 J.P. Morgan 42nd Annual Healthcare Conference Call January 8, 2024 9:00 AM ET Company Participants Vas Narasimhan - Chief Executive Officer Conference Call Participants Richard Vosser - J.P. Morgan Richard Vosser Welcome to the Novartis presentation at the 42nd J.P. Morgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst with J.P. Morgan. It's my great pleasure to welcome Vas Narasimhan, the CEO of Novartis today. Before I hand over to Vas, I'll just everyone; w ...

GSK plc (NYSE:GSK) 42nd Annual JP Morgan Healthcare Conference January 9, 2024 10:30 AM ET Company Participants Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer Tony Wood - Chief Scientific Officer Conference Call Participants James Gordon - JPMorgan James Gordon Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the GSK presentation. You're going to hear from GSK CEO, Emma Walmsley. Thanks a lot for join ...

Novo Nordisk A/S (NVO) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 12:45 PM ET Company Participants Lars Fruergaard Jorgensen - President & Chief Executive Officer Conference Call Participants Richard Vosser - JPMorgan Richard Vosser Welcome to the Novo Nordisk session at the 2024 JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to welcome the CEO of Novo, Lars Fruergaard Jorgensen to the conference for the first time. So ...

Thermo Fisher Scientific, Inc. (NYSE:TMO) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Marc Casper – Chief Executive Officer Conference Call Participants Rachel Vatnsdal – J.P. Morgan Rachel Vatnsdal Perfect. Good morning everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at J.P. Morgan. I'm joined on stage by Marc Casper, CEO of Thermo Fisher. So as we typically do, this is going to be a 40 minute session. First of it, h ...